Results 181 to 190 of about 65,523 (199)

Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis B. [PDF]

J Infect Dis
Ghorbani M, Kvedaraite A, Al-Manei K, Too CB, Cederberg S, Johannessen A, Reikvam DH, Valentini D, Maucourant C, Björkström NK, Aleman S, Sällberg Chen M.   +11 more
europepmc   +1 more source

True reactivation versus transient viremia: a retrospective analysis of HBV reactivation in resolved infection. [PDF]

Sci Rep
Inuzuka T, Takai A, Ueno M, Mishima M, Takeda H, Takahashi K, Kayahara T, Takabatake H, Mouri H, Seno H.   +9 more
europepmc   +1 more source

Weekly HBsAg Decline Dynamics During Combination Therapy with Interferon and Nucleos(t)ide Analogs: A Retrospective Real-World Study. [PDF]

Viruses
Yi Z, Huang Z, Duan C, Hu X, Chen D, Zhang J, Liu K, Du X, Sun C, Huang G.   +9 more
europepmc   +1 more source

Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B. [PDF]

JHEP Rep
Holmberg M, Niehrs A, Dalgard O, Berhe N, Desalegn H, Aleman S, Weis N, Stenstad T, Heggelund L, Samuelsen E, Karlsen LN, Lindahl K, Kleppa E, Winckelmann AA, Brugger-Synnes P, Simonsen HE, Svendsen J, Björkström NK, Reikvam DH, Johannessen A.   +19 more
europepmc   +1 more source

Combinatorial Therapy with Long-Acting Tenofovir and Tizoxanide Controls Viral Replication and Liver Inflammation in a Murine AAV-HBV Model of Chronic Hepatitis B. [PDF]

Biology (Basel)
Ogunnaike MO, Sultana A, Raut S, Wang W, Bybee G, Gendelman HE, Edagwa BJ, Osna NA, Poluektova LY.   +8 more
europepmc   +1 more source

No Immediate Need for Nucleos(t)ide Analogs Treatment in Untreated Patients With Low-Level Viremia: Evidence From Hepatitis B Virus RNA Levels. [PDF]

Clin Transl Gastroenterol
Zhang Y, Wu J, Gao H, Gao L, Wang L, Li T.   +5 more
europepmc   +1 more source

Synthesis of Novel d-Glucopyranuronamide-Based Nucleos(t)ide Analogs Bearing (Triazolyl)methyl Phosph(on)ate Motifs With Anticancer and Antibacterial Potential. [PDF]

ChemMedChem
Manuel DM, Moreira T, Filipe SR, Vojáčková V, Jorda R, Xavier NM.   +5 more
europepmc   +1 more source

12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue Therapy. [PDF]

Cancers (Basel)
Ikenaga H, Kozuka R, Inoue K, Matsubara T, Odagiri N, Yoshida K, Kotani K, Kawamura E, Hagihara A, Fujii H, Enomoto M, Uchida-Kobayashi S.   +11 more
europepmc   +1 more source

Persistent loss of intrahepatic IFN-γ in HBV is linked to selective impairment of liver-resident CXCR6+NK cells despite long-term NUC therapy. [PDF]

JHEP Rep
Beudeker BJB, Karaoglu DA, Nkongolo S, van Oord GW, Groothuismink ZMA, Lila KA, Gehring AJ, van den Bosch T, de Knegt RJ, van de Werken HJG, Boonstra A.   +10 more
europepmc   +1 more source

Temporal Association Between COVID-19 Vaccination and HBsAg Loss in Chronic Hepatitis B Infection: An Interrupted Time Series Analysis. [PDF]

Aliment Pharmacol Ther
Choi J, Carroll A, Nguyen VH, Michta M, Zhang XQ, Lim YS, Chung RT.   +6 more
europepmc   +1 more source